ロード中...
Sputum Streptococcus pneumoniae is reduced in COPD following treatment with benralizumab
We hypothesized whether the reduction in eosinophilic airway inflammation in patients with chronic obstructive pulmonary disease (COPD) following treatment with benralizumab, a humanized, afucosylated, monoclonal antibody that binds to interleukin-5 receptor α, increases the airway bacterial load. A...
保存先:
| 出版年: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6559763/ https://ncbi.nlm.nih.gov/pubmed/31239655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S198302 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|